Due to health issues, this site is no longer maintained and will be shut down shortly. |
We are a global, commercial-stage biopharmaceutical company dedicated to commercializing and developing novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:AMYT.
$14.59 0.00 (0.00%)
As of 03/27/2023 10:37:55 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.